|

My 5-MeO-DMT Psychedelic Experience in Tepotzlan Mexico | Tandava Retreats



In this short vlog, Swati Sharma, Media Director of PsychedelicSpotlight.com recounts her first experience with the psychedelic 5-MeO-DMT.

Follow us on Twitter: @PsycSpotlight

Follow us on Instagram: @psycspotlight

Like us on Facebook: https://www.facebook.com/PsychedelicSpotlight

To learn more about the emerging psychedelics industry, visit:

Psychedelic Spotlight

To partake in the psychedelic ceremony, Swati traveled to Tandava Retreats in Tepotzlan, Mexico. Was she healed by psychedelics? Did psychedelics help her mental health? What was the experience like? Watch the full video to find out!

In it, she discusses how her “ego death” affected her, and how great the team at Tandava Retreats was.

To learn more about Tandava retreats:
https://tandavaretreats.com/

Tune in to find out more!

Don’t forget to like and subscribe!
#5-MEO-DMT #egodeath #Psychedelics

source

Similar Posts

  • After MindMed, Which Psychedelic Stock Will UPLIST to the Nasdaq Next?(Numinus? Cybin? Field Trip?)

    Who’s next in line to Uplist to the Nasdaq? Numinus? Cybin? FieldTrip? ALL of them??
    Today, I’ll be covering an article by Jeff Neilson published on The Psychedelic Stock Watch. In this article, Jeff outlines several stocks as contenders for an uplisting.

    * Cybin Inc (CAN:CYBN / US:CLXPF) : Cybin is also one of the more successful companies in raising capital, having raised ~CAD$88.8 million (US$70 million) since going public last November and as we have been repeating on this channel, capital is a very important factor for the successful continuation and advancement of clinical trials.

    *Field Trip Health (CAN:FTRP / US:FTRPF) : Field Trip Health shares some similarities with Cybin as an uplisting prospect. It has raised even more capital than Cybin, in excess of US$100 million, including its recent CAD$95 million bought deal financing (US$76 million) and Field Trip has also a price target of CAD$8.50 price target from Stifel GMP to its February 2021 high of CAD$8.25.

    *Numinus Wellness (CAN:NUMI / US:LKYSF) : Numinus Wellness actually has a stronger following among retail investors than either Cybin or Field Trip. It was second only to MindMed as the volume leader among psychedelic stocks in the 2020 rally. It was also the second-best performer among all of the leading stocks in that rally, generating a 10X return at its 2020 peak.

    However, these are not the only psychedelic stocks to peak Jeff Neilson’s eye.
    He also mentions:

    Mind Cure Health (CAN:MCUR / US:MCURF)
    Mydecine Innovations Group (CAN:MYCO / US:MYCOF)
    Bright Minds Biosciences (CAN:DRUG / US:BMBIF)
    Small Pharma Inc( it hasn’t even started public trading YET)

    Timestamps:
    0:00 – Intro
    1:55 – Cybin ( CYBN / CXPF )
    6:13 – Field Trip Health ( FTRP / FTRPF )
    9:05 – Numinus Wellness ( NUMI / LKYSF )
    11:35 – Mindcure Health
    12:08 – Mydecine ( MYCO /MYCOF )
    12:34 – Bright Minds Biosciences ( DRUG / BMBIF )
    13:10 – Small Pharma Inc.

    Link to the article in question: https://psychedelicstockwatch.com/psychedelic-stock-news/the-next-psychedelic-stock-to-uplist-on-the-nasdaq?fbclid=IwAR3CgezfqtNHk0U3_YX5LYHDU2Y34jEFSTdNVGVchsKgR4CdEj58Q-lYcwk
    Link to Cybin (CYBN) : https://www.cybin.com/
    Link to Canacord: https://thetradingpriest.com/wp-content/uploads/2021/04/ResearchReport-1.pdf
    Link to Numinus (NUMI): https://numinus.ca/
    Link to Field Trip ( FTRP / FTRPF) : https://www.fieldtriphealth.com/

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #Cybin #Numi

  • Interview With Timothy Ko

    CEO of Entheon Biomedical, Timothy Ko, discusses how the company plans to utilize the psychedelic compound, DMT, to treat a variety of addictions.

  • Ask A Psychedelic Guide

    We welcome back Nick Levich for our “Ask a Psychedelic Professional” series and as part of our “Ask a Psychedelic Guide” episode.

  • MindMed’s Q2 Earnings Call: What does the future hold for MNMD/ MMED?

    Check out atai Life Sciences’ earnings call: https://www.youtube.com/watch?v=lkE3EmU0o_w

    What’s up psychedelic stocks investors?!? Today marked MindMed’s (MNMD /MMED) Second Quarter 2021 conference call. In the conference call, MindMed gave updates on their varying projects, such as treating anxiety with LSD, addiction with 18MC, and pain with LSD. They also give insights into their digital medicines division and gave an update on their hiring spree.

    This Kevin O’Leary-backed psychedelic therapies company is fighting for the title of the most advanced psychedelic stock. With 17+ different projects under their belt, MindMed is one of the most exciting companies to keep an eye on in the industry.

    This conference call can help investors answer the questions: is MNMD stock a good investment? Will MMED go up? Are psychedelic stocks / shroom stocks good investments? Can psychedelics heal depression? Can psychedelics be used for mental health?

    Enjoy the episode!

    Follow us on social media! 🙌
    Instagram: @thepsychedelicinvestor
    Facebook: @thepsychedelicinvestor

    Want to collaborate? Send us an email at:
    thepsychedelicinvestor@gmail.com

    Check out our website: thepsychedelicinvestor.com

    Check out our Benziga discounts
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    #MindMed #MNMD #PsychedelicStocks

  • MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED’s Psilocybin and LSD studies

    MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED’s Psilocybin and LSD studies.

    Mind Medicine (MindMed), (NASDAQ: MNMD, NEO: MMED, DE: MMQ), announced that Dr. Matthias Liechti presented data from several ongoing studies at the INSIGHT Conference in Berlin, Germany, conducted as part of MindMed’s ongoing collaboration with the UHB Liechti Lab.

    STUDIES:
    https://clinicaltrials.gov/ct2/show/NCT03912974?term=psilocybin+escitalopram&draw=2&rank=2

    https://clinicaltrials.gov/ct2/show/NCT03604744?term=LSD+PSilocybin&draw=2&rank=1

    https://mindmed.co/news/press-release/mindmed-and-liechti-lab-provide-results-from-their-psilocybin-rd-collaboration/?fbclid=IwAR2_2fUvNf-VTF36Sv6Oz-XB8PTjscqjMWMFF5CKBvKQU2yLMOI_ZP4aq18
    Enjoy the episode!

    Follow us on social media! 🙌
    Instagram: @thepsychedelicinvestor
    Facebook: @thepsychedelicinvestor

    Want to collaborate? Send us an email at:
    thepsychedelicinvestor@gmail.com

    Music from:
    www.bensound.com

    Video editing: @themyaholy

    Check out our Benziga discounts
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #mindmed #mmed #mnmdstock